The prevailing unhealthy food habits and hectic lifestyle of consumers across the world are the primary drivers of the global migraine drugs market. Further, the growing population and increasing awareness among consumers regarding the availability of the migraine treatment drugs are prominent factors fueling the growth in the global migraine drugs market. Furthermore, development of advanced drugs by the migraine drugs manufacturers is some other factor influencing growth in the market.

Report Summary: https://www.transparencymarketresearch.com/migraine-drugs-market.html

As per the Transparency Market Research, the global migraine drugs market reached a value of US$2.72 bn in 2016 and is expected to reach a value of US$3.72 bn by 2025. The global migraine drugs market is expected to register a steady CAGR 3.50% between 2017 and 2025. The market is mainly segmented into three segments namely Treatment, Route of Administration, and Distribution Channel.

From the perspective of treatment, the global migraine drugs market is divided into- Abortive, and Prophylactic segments. Further, Abortive segment is classified into triptans, alkoids, ergot and others based on the drug class. While prophylactic treatment is segmented into botulinum toxin, topiramate and others. Among these treatment segments, abortive procedure is likely to dominant market share in the global migraine drugs market whereas prophylactic treatment segment is projected to register a healthy growth during the forecast period that is from 2017 to 2025.

On the basis of route of administration segment, the global migraine drugs market is mainly segmented into oral, injectable and others. The other segment of route of administration includes nasal, spray, transdermal, patches and likewise. Among all of them, orally administrable drugs is likely to holds maximum potential for the global migraine market. And this is projected to continue in the upcoming years as well. This is mainly due to the low cost associated with the usage of oral drugs and vast availability of the oral drugs as compared to the other form across the globe. While on the basis of distribution channel the global migraine drugs market is segmented into hospital pharmacy and retail pharmacy.

Report Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=31136

Based on Geography the global migraine drugs market segment is classified into five prime regions: North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa. Among all these five region, North America is expected to account highest share in the global migraine drugs market during the upcoming years. This is mainly because of the increasing healthcare investment by the private and government bodies. Apart from this, increasing cases of migraine and easy avaiblity of the specialized migraine treatment are the some other headwinds propelling growth in the market. The region is anticipated to register a healthy 3.40% CAGR between 2017 and 2025.

The global migraine drug market depicts a fragmented competitive landscape owing to the presence of several players in the market. Some of the predominant players in the global migraine drugs market are Novartis AG, GlaxoSmithKline plc., Allergan Plc.,Avanir Pharmaceuticals, Inc., Janssen Pharmaceutical Company and ., Eisai Co.

Report Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=31136

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: [email protected]
Website: https://www.transparencymarketresearch.com